Group tasks 3

Development of technology tools to support the discovery, development and licensing of drugs for the treatment of diabetes and obesity

• GT Leader: IBMC, Partner 4
• Other participants: USC, INSERM, BIOCANT
• Start date: August 2009
• End date: October  2011
• Actions:
  • Obtaining of new miniaturized methods for the identification of compounds with anti-obesity or anti-diabetic activities
  • Development of tools for the rational design of  new compounds with anti-obesity or anti-diabetes activities
• Deliverables:
  • New miniaturized screening methods no.1, 2 , month 10, USC
  • Production of  recombinant protein 1, month 15, IBMC
  • New miniaturized screening method no.3, month 17, USC
  • Production of  recombinant protein 2, month 24, IBMC
  • Resolution of 3D structure of target protein(s), month 30, IBMC